Cite
HARVARD Citation
Kattamis, A. et al. (2018). Optimising management of deferasirox therapy for patients with transfusion‐dependent thalassaemia and lower‐risk myelodysplastic syndromes. European journal of haematology. pp. 272-282. [Online].